Rein Therapeutics Inc. (RNTX)

CTI BioPharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	7.43	12.87	17.31	5.19	3.6	7.05
Short-Term Investments	-	-	-	16.05	42.33	6.76
Cash & Short-Term Investments	7.43	12.87	17.31	21.24	45.93	13.81
Cash Growth	-38.32%	-25.69%	-18.50%	-53.75%	232.73%	-24.47%
Prepaid Expenses	-	-	-	0.61	2.22	1.93
Restricted Cash	-	-	0.03	0.03	0.03	0.59
Other Current Assets	0.9	0.79	0.93	-	-	-
Total Current Assets	8.33	13.66	18.27	21.87	48.18	16.33
Property, Plant & Equipment	0	0	0.02	0.11	0.28	0.02
Goodwill	6.33	6.33	6.33	-	-	-
Other Intangible Assets	42.2	42.2	79.2	-	-	-
Long-Term Deferred Charges	-	-	2.14	-	-	-
Other Long-Term Assets	0.77	0	0.05	0.02	0.02	-
Total Assets	57.63	62.19	106.01	22.01	48.48	16.34
Accounts Payable	1.15	0.91	1.19	1.72	1.21	1.6
Accrued Expenses	4.66	4.72	2.94	1.45	3.15	1.95
Current Portion of Long-Term Debt	-	-	-	-	-	0.17
Current Portion of Leases	-	-	0.05	0.03	0.09	-
Other Current Liabilities	0.16	0.12	0.21	0.18	0.06	0.24
Total Current Liabilities	5.98	5.75	4.39	3.38	4.51	3.96
Long-Term Debt	-	-	-	-	-	0.22
Long-Term Leases	-	-	-	-	0.07	-
Long-Term Deferred Tax Liabilities	1.77	1.77	3.33	-	-	-
Other Long-Term Liabilities	-	0.28	-	-	-	-
Total Liabilities	7.75	7.8	7.71	3.38	4.58	4.18
Common Stock	0.11	0.11	0.09	0.09	0.09	0.04
Additional Paid-In Capital	361.7	360.7	295.38	291.37	289.28	231.41
Retained Earnings	-356.9	-351.4	-288.52	-272.79	-245.46	-219.29
Comprehensive Income & Other	-0.03	-0.02	-0.06	-0.05	-0.01	-0
Total Common Equity	4.87	9.39	6.89	18.62	43.9	12.16
Shareholders' Equity	49.88	54.39	98.3	18.62	43.9	12.16
Total Liabilities & Equity	57.63	62.19	106.01	22.01	48.48	16.34
Total Debt	-	-	0.05	0.03	0.16	0.39
Net Cash (Debt)	7.43	12.87	17.27	21.21	45.77	13.42
Net Cash Growth	-38.32%	-25.49%	-18.60%	-53.66%	241.12%	1.30%
Net Cash Per Share	0.35	0.72	3.75	4.67	10.31	7.70
Filing Date Shares Outstanding	22.15	21.99	16.97	4.54	4.53	4.51
Total Common Shares Outstanding	22.01	21.67	4.89	4.54	4.53	2.19
Working Capital	2.35	7.91	13.88	18.49	43.67	12.37
Book Value Per Share	0.22	0.43	1.41	4.10	9.69	5.55
Tangible Book Value	-43.66	-39.14	-78.64	18.62	43.9	12.16
Tangible Book Value Per Share	-1.98	-1.81	-16.10	4.10	9.69	5.55
Machinery	-	-	-	0.34	0.34	-

Updated Apr 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q